CAM
TMDX icon

Cresset Asset Management’s Transmedics TMDX Stock Holding History

Cresset Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$263K Buy
+2,648
New +$345K ﹤0.01% 1332
2024
Q2 		– Sell
-5,136
Closed -$380K – 2169
2024
Q1 		$380K Buy
+5,136
New +$423K ﹤0.01% 1470

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cresset Asset Management's TMDX Position: Q1 2026 in Review

Cresset Asset Management opened a new position in Transmedics (TMDX) in Q1 2026: 2,648 shares worth $263K. The stake represents ﹤0.01% of the portfolio and ranks #1332 among its holdings. This is a return to the name: Cresset Asset Management previously reported a position in TMDX as recently as Q1 2024.

Cresset Asset Management first reported a position in TMDX in Q1 2024 and has held it in 2 quarters since. The position peaked at $380K in Q1 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Cresset Asset Management held 2,648 shares of Transmedics worth $263K as of Q1 2026.
  • Transmedics was a new Cresset Asset Management position in Q1 2026.
  • Transmedics made up ﹤0.01% of Cresset Asset Management's portfolio in Q1 2026, its #1332 holding.
  • Cresset Asset Management first reported a position in Transmedics in Q1 2024 and has held it in 2 quarters since.
  • Cresset Asset Management's Transmedics position peaked at $380K in Q1 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.